256 related articles for article (PubMed ID: 25890381)
1. Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model.
Noorani L; Stenzel M; Liang R; Pourgholami MH; Morris DL
J Nanobiotechnology; 2015 Mar; 13():25. PubMed ID: 25890381
[TBL] [Abstract][Full Text] [Related]
2. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice.
Pourgholami MH; Yan Cai Z; Lu Y; Wang L; Morris DL
Clin Cancer Res; 2006 Mar; 12(6):1928-35. PubMed ID: 16551879
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cell proliferation, vascular endothelial growth factor and tumor growth by albendazole.
Pourgholami MH; Cai ZY; Wang L; Badar S; Links M; Morris DL
Cancer Invest; 2009 Feb; 27(2):171-7. PubMed ID: 19235589
[TBL] [Abstract][Full Text] [Related]
4. Potent inhibition of tumoral hypoxia-inducible factor 1alpha by albendazole.
Pourgholami MH; Cai ZY; Badar S; Wangoo K; Poruchynsky MS; Morris DL
BMC Cancer; 2010 Apr; 10():143. PubMed ID: 20398289
[TBL] [Abstract][Full Text] [Related]
5. Albendazole inhibits HIF-1α-dependent glycolysis and VEGF expression in non-small cell lung cancer cells.
Zhou F; Du J; Wang J
Mol Cell Biochem; 2017 Apr; 428(1-2):171-178. PubMed ID: 28063005
[TBL] [Abstract][Full Text] [Related]
6. (cRGD)2 peptides modified nanoparticles increase tumor-targeting therapeutic effects by co-delivery of albendazole and iodine-131.
Liu S; Liu H; Sun H; Deng S; Yue L; Weng Z; Yang J; Zuo B; He Y; Zhang B
Anticancer Drugs; 2022 Jan; 33(1):19-29. PubMed ID: 34261920
[TBL] [Abstract][Full Text] [Related]
7. Acyclic Cucurbit[n]uril-Type Molecular Container Enables Systemic Delivery of Effective Doses of Albendazole for Treatment of SK-OV-3 Xenograft Tumors.
Hettiarachchi G; Samanta SK; Falcinelli S; Zhang B; Moncelet D; Isaacs L; Briken V
Mol Pharm; 2016 Mar; 13(3):809-18. PubMed ID: 26756920
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
Pourgholami MH; Akhter J; Wang L; Lu Y; Morris DL
Cancer Chemother Pharmacol; 2005 May; 55(5):425-32. PubMed ID: 15565325
[TBL] [Abstract][Full Text] [Related]
9. Anticancer activity and molecular mechanism of resveratrol-bovine serum albumin nanoparticles on subcutaneously implanted human primary ovarian carcinoma cells in nude mice.
Guo L; Peng Y; Yao J; Sui L; Gu A; Wang J
Cancer Biother Radiopharm; 2010 Aug; 25(4):471-7. PubMed ID: 20735207
[TBL] [Abstract][Full Text] [Related]
10. The influence of ovarian cancer induced peritoneal carcinomatosis on the pharmacokinetics of albendazole in nude mice.
Pourgholami MH; Cai ZY; Chu SW; Galettis P; Morris DL
Anticancer Res; 2010 Feb; 30(2):423-8. PubMed ID: 20332449
[TBL] [Abstract][Full Text] [Related]
11. Solid Lipid Nanoparticles of Albendazole for Enhancing Cellular Uptake and Cytotoxicity against U-87 MG Glioma Cell Lines.
Marslin G; Siram K; Liu X; Khandelwal VKM; Xiaolei S; Xiang W; Franklin G
Molecules; 2017 Nov; 22(11):. PubMed ID: 29165384
[TBL] [Abstract][Full Text] [Related]
12. Albendazole-cyclodextrin complex: enhanced cytotoxicity in ovarian cancer cells.
Pourgholami MH; Wangoo KT; Morris DL
Anticancer Res; 2008; 28(5A):2775-9. PubMed ID: 19035309
[TBL] [Abstract][Full Text] [Related]
13. Albendazole-loaded cubosomes interrupt the ERK1/2-HIF-1α-p300/CREB axis in mice intoxicated with diethylnitrosamine: A new paradigm in drug repurposing for the inhibition of hepatocellular carcinoma progression.
Saber S; Nasr M; Saad AS; Mourad AAE; Gobba NA; Shata A; Hafez AM; Elsergany RN; Elagamy HI; El-Ahwany E; Amin NA; Girgis S; Elewa YHA; Mahmoud MH; Batiha GE; El-Rous MA; Kamal I; Kaddah MMY; Khodir AE
Biomed Pharmacother; 2021 Oct; 142():112029. PubMed ID: 34416629
[TBL] [Abstract][Full Text] [Related]
14. Complexation of albendazole with hydroxypropyl-β-cyclodextrin significantly improves its pharmacokinetic profile, cell cytotoxicity and antitumor efficacy in nude mice.
Ehteda A; Galettis P; Chu SW; Pillai K; Morris DL
Anticancer Res; 2012 Sep; 32(9):3659-66. PubMed ID: 22993303
[TBL] [Abstract][Full Text] [Related]
15. Potent inhibition of tubulin polymerisation and proliferation of paclitaxel-resistant 1A9PTX22 human ovarian cancer cells by albendazole.
Chu SW; Badar S; Morris DL; Pourgholami MH
Anticancer Res; 2009 Oct; 29(10):3791-6. PubMed ID: 19846910
[TBL] [Abstract][Full Text] [Related]
16. Differential effect of intraperitoneal albendazole and paclitaxel on ascites formation and expression of vascular endothelial growth factor in ovarian cancer cell-bearing athymic nude mice.
Choi EK; Kim SW; Nam EJ; Paek J; Yim GW; Kang MH; Kim YT
Reprod Sci; 2011 Aug; 18(8):763-71. PubMed ID: 21421899
[TBL] [Abstract][Full Text] [Related]
17. Normalization of the ovarian cancer microenvironment by SPARC.
Said N; Socha MJ; Olearczyk JJ; Elmarakby AA; Imig JD; Motamed K
Mol Cancer Res; 2007 Oct; 5(10):1015-30. PubMed ID: 17951402
[TBL] [Abstract][Full Text] [Related]
18. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug.
Battogtokh G; Kang JH; Ko YT
Eur J Pharm Biopharm; 2015 Oct; 96():96-105. PubMed ID: 26212785
[TBL] [Abstract][Full Text] [Related]
19. Novel albendazole-chitosan nanoparticles for intestinal absorption enhancement and hepatic targeting improvement in rats.
Liu Y; Wang XQ; Ren WX; Chen YL; Yu Y; Zhang JK; Bawudong D; Gu JP; Xu XD; Zhang XN
J Biomed Mater Res B Appl Biomater; 2013 Aug; 101(6):998-1005. PubMed ID: 23529958
[TBL] [Abstract][Full Text] [Related]
20. The potential use of lapatinib-loaded human serum albumin nanoparticles in the treatment of triple-negative breast cancer.
Wan X; Zheng X; Pang X; Zhang Z; Jing T; Xu W; Zhang Q
Int J Pharm; 2015 Apr; 484(1-2):16-28. PubMed ID: 25700543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
